What is HER2 positive breast cancer? If your pathology report says HER2 positive, you may be meeting a term you have never heard before at a moment when you are already taking in a great deal. HER2 is not a separate disease. It is one detail about how your particular cancer behaves, and it helps doctors choose treatments that can work well against it.
This guide explains what HER2 is, what positive means, how the testing works, and which targeted treatments doctors often use. Knowing what the words mean can make your results, and the conversations that follow, feel clearer and less frightening.
What HER2 Is and What Positive Means
HER2 is a protein that sits on the surface of cells, including breast cells. In healthy tissue it helps control how cells grow and divide. Every breast cell carries copies of the HER2 gene, which gives the instructions for making this protein.
In some breast cancers, the cancer cells carry too many copies of the gene, and so they make far too much of the protein. Doctors call this HER2 positive. The extra protein sends strong grow signals, so these cancers can grow more quickly than some others. The important part is that treatments exist which are designed to block those signals.
How Common This Type Is and Who Gets It
Roughly one in five breast cancers is HER2 positive. It can occur at almost any adult age, and it is seen a little more often in younger women than some other types. Men can also develop HER2 positive breast cancer, although breast cancer in men is uncommon overall.
Being HER2 positive is not caused by anything you did, and it is not usually inherited from a parent. It is a change that happens inside the cancer cells themselves. Your team will find it through testing, whatever your age or family history.
Symptoms and How It Is Found
HER2 positive breast cancer does not have its own special symptoms. It is usually found the same way as other breast cancers: through a lump or another breast change that is then checked with imaging and a biopsy, or through a screening mammogram that spots something early.
The type is worked out in the laboratory after the biopsy, not from how the cancer looks or feels. That is why the pathology report matters so much: it tells your team the details that shape your treatment plan, including the HER2 result.
The Two Main HER2 Tests Explained Simply
The first test, called IHC, uses special stains on the biopsy sample to measure how much HER2 protein sits on the cancer cells. The result is a score. A score of 0 or 1 plus means very little protein, and the cancer is treated as HER2 negative. A score of 3 plus means plenty of protein, and the cancer is HER2 positive.
The second test, called FISH, looks directly at the cancer cells to count copies of the HER2 gene itself. It is often used when the IHC score is 2 plus, which sits in the middle and is not clear on its own. Your report may describe your result in these terms, and your team can talk you through your own numbers.
Targeted Treatments and How They Fit With Other Care
HER2 positive cancers can be treated with targeted medicines that are designed to find HER2 and block the grow signals it sends. These medicines are often given alongside chemotherapy, and some are given as a drip in the treatment unit while others come in other forms your team will explain.
The rest of your plan may include surgery and radiation, much like other breast cancers, and hormone therapy is added if your cancer is also hormone receptor positive. Treatment is usually planned as a combination, and your team will explain the order and timing for your situation.
Outlook and Questions to Ask Your Team
Years ago, HER2 positive cancer was considered one of the more worrying types because it could grow quickly. Targeted treatments have changed that picture a great deal, and outcomes for many people are now much better than they once were. Your own outlook depends on the size and stage of your cancer and how it responds to treatment.
Questions that can help at appointments include: What was my exact HER2 result? Will I be offered targeted treatment, and in what order with my other care? How will we know the treatment is working? Writing questions down before you go, and bringing someone with you, can make these conversations easier.
Frequently Asked Questions
Is HER2 positive breast cancer inherited?
Usually not. The HER2 change is found in the cancer cells and is not something you are born with in every cell of your body, so it is not normally passed down in families. Separately, some families carry inherited gene changes that raise breast cancer risk, and your team may discuss genetic testing if your history suggests it.
Can a HER2 result change or be wrong?
Results are carefully checked, but testing a small sample can occasionally give a borderline answer, which is why the second test exists. Results can also differ slightly between samples from different parts of a cancer. If anything about your result is unclear, ask your team to explain how confident they are in it.
If I am HER2 positive, will I definitely have chemotherapy?
Most treatment plans for HER2 positive cancer include chemotherapy alongside targeted medicines, because the two work well together. For very small cancers with no lymph node involvement, plans can sometimes be gentler. Your team will explain what is recommended in your case and why.
A Note on Medical Information
The information on this website is for general educational purposes only and is not medical advice. It does not replace the advice, diagnosis, or treatment of a qualified healthcare professional. If you notice a change in your breast or have concerns about your health, please contact a healthcare professional promptly.